A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

Clicks: 399
ID: 112421
1987
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
A model was designed to examine the relations between incremental costs and benefits of coronary thrombolysis/reperfusion therapy. The model allows for the study of intravenous and intracoronary streptokinase, intravenous tissue plasminogen activator and primary angioplasty. Three strategies for the …
Reference Key
gl1987journala Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Laffel GL;Fineberg HV;Braunwald E;;
Journal Journal of the American College of Cardiology
Year 1987
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/2959718
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine models Recurrence risk factors time factors decision trees theoretical* cost-benefit analysis pmid:2959718 doi:10.1016/s0735-1097(87)80432-1 g l laffel h v fineberg e braunwald angioplasty balloon / economics* coronary angiography coronary disease / economics* coronary thrombosis / economics* coronary thrombosis / mortality coronary thrombosis / therapy coronary vessels* drug evaluation myocardial infarction / economics myocardial infarction / mortality myocardial infarction / therapy stroke volume / drug effects willingness to pay myocardium intravenous primary angioplasty thrombolysis/reperfusion therapy reocclusion coronary occlusion

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.